Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant human LILRB5 / CD85c / LIR-8 Protein, His Tag, 100 µg  

Recombinant human LILRB5 / CD85c / LIR-8 Protein, His Tag, 100 µg

Recombinant human LILRB5 / CD85c / LIR-8, Gly 24 - Gly 458, expressed from human 293 cells (HEK293), His Tag

Synonym
Recombinant human protein, LILRB5,CD85c,LIR-8

More details

CDC-H5220-100

Availability: within 7 days

455,00 €

Background
Leukocyte immunoglobulin-like receptor subfamily B member 5 (LILRB5), also known as CD85c and LIR-8, belongs to the leukocyte immunoglobulin-like receptor (LIR) family of transmembrane glycoproteins that negatively regulate immune cell activation. Several other LIR subfamily B receptors are expressed on immune cells where they bind to MHC class I molecules on antigen-presenting cells and inhibit stimulation of an immune response.

Source
Recombinant Human LILRB5, His Tag (CDC-H5220) is expressed from human 293 cells (HEK293). It contains AA Gly 24 - Gly 458 (Accession # NP_006831).
Predicted N-terminus: Gly 24

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 49.2 kDa. The protein migrates as 66-68 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 1.0 EU per μg by the LAL method.
 
Purity
>95% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Clinical and Translational Updates

(1) "Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial"
Murphy, Lin, Damask et al
Circ Genom Precis Med (2022) 15 (3), e003503
(2) "A Pilot Study of Whole-Blood Transcriptomic Analysis to Identify Genes Associated with Repetitive Low-Level Blast Exposure in Career Breachers"
Vorn, Edwards, Hentig et al
Biomedicines (2022) 10 (3)
(3) "Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer"
Fan, Wang, Chen et al
World J Surg Oncol (2022) 20 (1), 92
Showing 1-3 of 18 papers.